Data updated: Mar 10, 2026
SECOBARBITAL SODIUM
SECOBARBITAL SODIUM
Approved 1973-12-03
8
Indications
--
Phase 3 Trials
52
Years on Market
Details
- Status
- Discontinued
- First Approved
- 1973-12-03
- Routes
- ORAL, INJECTION
- Dosage Forms
- CAPSULE, INJECTABLE
Companies
EVERYLIFE Pfizer KV PHARM ELKINS SINN ANABOLIC PERRIGO HALSEY PARKE DAVIS Hikma LANNETT VALEANT PHARM INTL WATSON LABS WHITEWORTH TOWN PLSN Teva VITARINE IVAX PHARMS PUREPAC PHARM
Active Ingredient: SECOBARBITAL SODIUM
Website: ↗
SECOBARBITAL SODIUM Approval History
Loading approval history...
What SECOBARBITAL SODIUM Treats
8 FDA approvalsOriginally approved for its first indication in 1973 . Covers 8 distinct patient populations.
- Other (8)
Other
(8 approvals)- • Approved indication (Dec 1973)
- • Approved indication (Apr 1975)
- • Approved indication (Dec 1976)
- • Approved indication (Oct 1977)
- • Approved indication (Apr 1978)
- • Approved indication (Jun 1978)
- • Approved indication (Oct 1978)
- • Approved indication (Dec 1981)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
SECOBARBITAL SODIUM FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.